Estadístiques de Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients

Visites totals

views
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients 1

Visites totals per mes

views
May 2025 0
June 2025 0
July 2025 0
August 2025 0
September 2025 0
October 2025 0
November 2025 0

Visites al fitxer

views
Brahmer_ejc_safe.pdf 81
Brahmer_ejc_safe.pdf(legacy) 3